Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria.

Ajogbasile FV, Oguzie JU, Oluniyi PE, Eromon PE, Uwanibe JN, Mehta SB, Siddle KJ, Odia I, Winnicki SM, Akpede N, Akpede G, Okogbenin S, Ogbaini-Emovon E, MacInnis BL, Folarin OA, Modjarrad K, Schaffner SF, Tomori O, Ihekweazu C, Sabeti PC, Happi CT.

Sci Rep. 2020 Feb 21;10(1):3180. doi: 10.1038/s41598-020-59880-w.

2.

Nigeria's Joint External Evaluation and National Action Plan for Health Security.

Ojo OE, Dalhat M, Garfield R, Lee C, Oyebanji O, Oyetunji A, Ihekweazu C.

Health Secur. 2020 Jan/Feb;18(1):16-20. doi: 10.1089/hs.2019.0051.

PMID:
32078417
3.

Clinical course and outcome of human monkeypox in Nigeria.

Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P, Otike-Odibi B, Muhammed Usman L, Obazee E, Aruna O, Ihekweazu C.

Clin Infect Dis. 2020 Feb 13. pii: ciaa143. doi: 10.1093/cid/ciaa143. [Epub ahead of print]

PMID:
32052029
4.

Improving Cross-Border Preparedness and Response: Lessons Learned from 3 Lassa Fever Outbreaks Across Benin, Nigeria, and Togo, 2017-2019.

Kakaī CG, Okunromade OF, Dan-Nwafor CC, Chabi AIB, Martial GTP, Dalhat MM, Ward S, Tante O, Nguku PM, Hamadi A, Ilori E, Lokossou V, Brito C, Ojo OE, Kone I, Agbeko TT, Ihekweazu C, Merrill RD.

Health Secur. 2020 Jan;18(S1):S105-S112. doi: 10.1089/hs.2019.0080.

PMID:
32004125
5.

Use of Surveillance Outbreak Response Management and Analysis System for Human Monkeypox Outbreak, Nigeria, 2017-2019.

Silenou BC, Tom-Aba D, Adeoye O, Arinze CC, Oyiri F, Suleman AK, Yinka-Ogunleye A, Dörrbecker J, Ihekweazu C, Krause G.

Emerg Infect Dis. 2020 Feb;26(2):345-349. doi: 10.3201/eid2602.191139.

6.

Epidemiology and case-control study of Lassa fever outbreak in Nigeria from 2018 to 2019.

Ipadeola O, Furuse Y, Ilori EA, Dan-Nwafor CC, Akabike KO, Ahumibe A, Ukponu W, Bakare L, Joseph G, Saleh M, Muwanguzi EN, Olayinka A, Namara G, Naidoo D, Iniobong A, Amedu M, Ugbogulu N, Makava F, Adeoye O, Uzoho C, Anueyiagu C, Okwor TJ, Mba NG, Akano A, Ogunniyi A, Mohammed A, Adeyemo A, Ugochukwu DK, Agogo E, Ihekweazu C.

J Infect. 2020 Jan 8. pii: S0163-4453(20)30001-3. doi: 10.1016/j.jinf.2019.12.020. [Epub ahead of print] No abstract available.

PMID:
31926184
7.

Sequelae of Lassa Fever: Postviral Cerebellar Ataxia.

Ezeomah C, Adoga A, Ihekweazu C, Paessler S, Cisneros I, Tomori O, Walker D.

Open Forum Infect Dis. 2019 Dec 3;6(12):ofz512. doi: 10.1093/ofid/ofz512. eCollection 2019 Dec. Review.

8.

Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission.

Lee VJ, Aguilera X, Heymann D, Wilder-Smith A; Lancet Infectious Diseases Commission.

Lancet Infect Dis. 2020 Jan;20(1):17-19. doi: 10.1016/S1473-3099(19)30674-7. No abstract available.

PMID:
31876487
9.

Performance of the Public Health System During a Full-Scale Yellow Fever Simulation Exercise in Lagos State, Nigeria, in 2018: How Prepared Are We for the Next Outbreak?

Okunromade OF, Lokossou VK, Anya I, Dada AO, Njidda AM, Disu YO, Dalhat MM, Brito CF, Balogun MS, Nguku P, Ojo OE, Ihekweazu C, Okolo S.

Health Secur. 2019 Nov/Dec;17(6):485-494. doi: 10.1089/hs.2019.0048.

PMID:
31859573
10.

Accelerating Action in Global Health Security: Global Biosecurity Dialogue as a Model for Advancing the Global Health Security Agenda.

Brizee S, Budeski K, James W, Nalabandian M, Bleijs DA, Becker SJ, Wallace-Sankarsingh S, Ahumibe A, Agogo E, Ihekweazu C, Nikkari S, Ellis M, Gozzer E, Semesi IS, Masuku ZM, Ikram A, Tahir F, Makalinao I, Severance HA, van Passel MWJ, Cameron EE.

Health Secur. 2019 Nov/Dec;17(6):495-503. doi: 10.1089/hs.2019.0121.

PMID:
31859570
11.

Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.

Babalola SO, Babatunde JA, Remilekun OM, Amaobichukwu AR, Abiodun AM, Jide I, Adeshina AI, Chikwe I, Aremu OS.

Pan Afr Med J. 2019 Oct 6;34:76. doi: 10.11604/pamj.2019.34.76.16425. eCollection 2019.

12.

Lay media reporting of monkeypox in Nigeria.

Oyebanji O, Ofonagoro U, Akande O, Nsofor I, Ukenedo C, Mohammed TB, Anueyiagu C, Agenyi J, Yinka-Ogunleye A, Ihekweazu C.

BMJ Glob Health. 2019 Nov 12;4(6):e002019. doi: 10.1136/bmjgh-2019-002019. eCollection 2019. No abstract available.

13.

A new twenty-first century science for effective epidemic response.

Bedford J, Farrar J, Ihekweazu C, Kang G, Koopmans M, Nkengasong J.

Nature. 2019 Nov;575(7781):130-136. doi: 10.1038/s41586-019-1717-y. Epub 2019 Nov 6. Review.

PMID:
31695207
14.

Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.

Cooper LV, Ronveaux O, Fernandez K, Lingani C, Goumbi K, Ihekweazu C, Preziosi MP, Durupt A, Trotter CL.

J Infect Dis. 2019 Oct 31;220(Supplement_4):S244-S252. doi: 10.1093/infdis/jiz343.

15.

Lassa Fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention.

Asogun DA, Günther S, Akpede GO, Ihekweazu C, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):933-951. doi: 10.1016/j.idc.2019.08.002. Review.

PMID:
31668199
16.

Corrigendum: Caseload and Case Fatality of Lassa Fever in Nigeria, 2001-2018: A Specialist Center's Experience and Its Implications.

Akpede GO, Asogun DA, Okogbenin SA, Dawodu SO, Momoh MO, Dongo AE, Ike C, Tobin E, Akpede N, Ogbaini-Emovon E, Adewale AE, Ochei O, Onyeke F, Okonofua MO, Atafo RO, Odia I, Adomeh DI, Odigie G, Ogbeifun C, Muoebonam E, Ihekweazu C, Ramharter M, Colubri A, Sabeti PC, Happi CT, Günther S, Agbonlahor DE.

Front Public Health. 2019 Sep 13;7:251. doi: 10.3389/fpubh.2019.00251. eCollection 2019.

17.

Learning from the Epidemiological Response to the 2014/15 Ebola Virus Disease Outbreak.

Holding M, Ihekweazu C, Stuart JM, Oliver I.

J Epidemiol Glob Health. 2019 Sep;9(3):169-175. doi: 10.2991/jegh.k.190808.002.

PMID:
31529934
18.

Descriptive epidemiology of cholera outbreak in Nigeria, January-November, 2018: implications for the global roadmap strategy.

Elimian KO, Musah A, Mezue S, Oyebanji O, Yennan S, Jinadu A, Williams N, Ogunleye A, Fall IS, Yao M, Eteng WE, Abok P, Popoola M, Chukwuji M, Omar LH, Ekeng E, Balde T, Mamadu I, Adeyemo A, Namara G, Okudo I, Alemu W, Peter C, Ihekweazu C.

BMC Public Health. 2019 Sep 13;19(1):1264. doi: 10.1186/s12889-019-7559-6.

19.

Caseload and Case Fatality of Lassa Fever in Nigeria, 2001-2018: A Specialist Center's Experience and Its Implications.

Akpede GO, Asogun DA, Okogbenin SA, Dawodu SO, Momoh MO, Dongo AE, Ike C, Tobin E, Akpede N, Ogbaini-Emovon E, Adewale AE, Ochei O, Onyeke F, Okonofua MO, Atafo RO, Odia I, Adomeh DI, Odigie G, Ogbeifun C, Muebonam E, Ihekweazu C, Ramharter M, Colubri A, Sarbeti PC, Happi CT, Günther S, Agbonlahor DE.

Front Public Health. 2019 Jun 25;7:170. doi: 10.3389/fpubh.2019.00170. eCollection 2019. Erratum in: Front Public Health. 2019 Sep 13;7:251.

20.

Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report.

Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, Mamadu I, Akinpelu A, Ahmad A, Burga J, Ndoreraho A, Nkunzimana E, Manneh L, Mohammed A, Adeoye O, Tom-Aba D, Silenou B, Ipadeola O, Saleh M, Adeyemo A, Nwadiutor I, Aworabhi N, Uke P, John D, Wakama P, Reynolds M, Mauldin MR, Doty J, Wilkins K, Musa J, Khalakdina A, Adedeji A, Mba N, Ojo O, Krause G, Ihekweazu C; CDC Monkeypox Outbreak Team.

Lancet Infect Dis. 2019 Aug;19(8):872-879. doi: 10.1016/S1473-3099(19)30294-4. Epub 2019 Jul 5.

PMID:
31285143

Supplemental Content

Loading ...
Support Center